Introduction
Medical device registration in Australia is the structured regulatory and operational function through which a business determines whether a product is regulated as a medical device, identifies the applicable class and secures lawful market access through the Therapeutic Goods Administration framework.
In practical terms, the Australian route revolves around inclusion in the Australian Register of Therapeutic Goods, sponsor-led market access and continuing compliance obligations after supply begins.
The subject is commercially important because a device must generally reach the correct TGA position before it can be legally supplied in Australia, and mistakes around classification, sponsor structure or ARTG inclusion can block market entry and create enforcement risk.
Home
└── Jurisdictions
└── Australia
└── Medical Device Registration Australia
Identity
- Object: Medical Device Registration
- Jurisdiction: Australia
- Object ID: AU.MDR.001
- Reference: MAR-AU-MDR-001-A
Core Framework
- TGA-centered regulation of medical devices
- ARTG inclusion as the core legal-supply reference point
- Sponsor-based market-access structure
- Class-based assessment and post-market obligations
Operating Logic
- Determine whether the product is a therapeutic good and medical device
- Confirm whether ARTG inclusion is required
- Use an Australian sponsor structure for supply
- Maintain compliance during supply, import, storage and post-market monitoring
Executive Summary
Medical device registration in Australia is the professional regulatory and market-access function concerned with determining whether a product qualifies as a medical device under the Australian framework, identifying its class and achieving the legal position required for supply through the TGA system.
The TGA states that a medical device can be any product or software, including AI, that works to achieve a therapeutic purpose in or on human beings. The same TGA framework explains that medical-device regulation in Australia spans manufacturing, application and market authorisation, supply and distribution, labelling and advertising, and monitoring and compliance. [page:1]
Australian market access is closely connected to the Australian Register of Therapeutic Goods. The TGA states that the ARTG is the public database of therapeutic goods that can be legally supplied in Australia. [web:98][page:2]
Registration analysis in Australia is therefore not just a filing exercise. It requires a business to determine whether the product is a therapeutic good, whether it needs to be included in the ARTG and whether the sponsor-led supply structure is set up correctly for lawful supply. [web:92][page:1][page:2]
| Definition | The professional regulatory and market-access function concerned with securing the lawful TGA and ARTG position required for a medical device to be supplied in Australia. |
| Object | Medical Device Registration |
| Object Type | Professional Regulatory and Market-Access Function |
| Classification | Medical Devices, Australia, TGA, ARTG, Sponsor, Therapeutic Goods, Class-Based Regulation, Market Access |
| Jurisdiction | Australia |
Definition
Medical device registration in Australia refers to the structured process through which a business determines whether its product is regulated as a medical device or IVD medical device, identifies the relevant Australian class or inclusion logic and secures the TGA and ARTG position needed for lawful supply.
The object is broader than searching the register. It covers product qualification, therapeutic-good analysis, class determination, sponsor structure, ARTG inclusion logic, documentation readiness and continuing post-market responsibilities.
| Covered Matters | Therapeutic-good qualification, medical-device assessment, class analysis, ARTG inclusion, sponsor structure, market authorisation readiness and ongoing supply compliance. |
| Functional Boundary | The Registry Object covers how businesses achieve and maintain lawful Australian market access for medical devices. |
| Related but Not Primary | Hospital procurement, private reimbursement, state purchasing rules and general distributor contracting are adjacent but not the primary object here. |
| Outside Scope | Pharmaceutical authorisation, unrelated therapeutic goods categories, company incorporation and generic commercial strategy unrelated to device lawfulness. |
Scope
The Australian medical device registration function applies to products regulated by the TGA as medical devices or IVD medical devices and to the market participants responsible for lawful supply in Australia. The TGA states that the medical-device journey includes application and market authorisation, supply and distribution, labelling and advertising, and monitoring and compliance. [page:1]
The scope question starts with product identity. TGA guidance on whether a product needs to be in the ARTG instructs businesses to determine whether the product is a therapeutic good and whether it is a medical device that needs ARTG inclusion. [web:92]
Editorial Note: In Australia, a registration review is incomplete if it does not first answer two threshold questions: is the product a therapeutic good, and if so, does it need to be included in the ARTG before supply? [web:92][page:2]
Purpose
The purpose of medical device registration in Australia is to convert a product, evidence base and supply model into a lawful TGA market-entry position.
In business terms, the function exists to identify the correct class-based route, confirm whether ARTG inclusion is required, align the sponsor structure and reduce the risk of supplying a device in Australia without the correct legal basis.
Primary Outcome
A coherent Australian medical device registration position means that the product has been qualified correctly, matched to the relevant class-based route and linked to the sponsor and ARTG architecture required for lawful supply.
For devices that must be included in the ARTG, the practical outcome is a register position that can be checked in the public ARTG database, which the TGA describes as the public database of therapeutic goods that can be legally supplied in Australia. [web:98][page:2]
Request Contexts
Request contexts show the business situations in which Australian registration work is typically activated. Most begin before launch, but the function is also relevant when changing sponsor arrangements, checking ARTG status or reviewing supply-chain readiness.
| Identity Pattern | Manufacturer planning Australian entry, sponsor evaluating inclusion readiness, regulatory lead checking class and ARTG strategy, importer or distributor validating lawful supply position. |
| Business Event | First Australian launch, therapeutic-good uncertainty, class review, ARTG inclusion planning, sponsor appointment, register verification, post-market update or distribution-structure change. |
| Typical User | Manufacturers, Australian sponsors, regulatory affairs managers, importers, distributors, legal advisers and international medtech businesses. |
| Typical Scenario | A company wants to supply a device in Australia and must determine whether the product is a medical device, whether it needs ARTG inclusion and which sponsor structure should carry the market-access responsibility. [web:92][page:1][page:2] |
Typical Users
Different actors approach Australian registration from different positions, but all need a defensible answer on qualification, sponsor structure and register status.
| Manufacturer | Needs to determine whether the product is regulated as a medical device in Australia and what class-based route applies. [page:1][web:92] |
| Australian Sponsor | Needs to manage ARTG inclusion, maintain the supply relationship and respond to TGA-facing obligations attached to supply and distribution. [page:1][page:2] |
| Importer or Distributor | Needs clarity on whether the product can be legally supplied and whether sponsor-linked compliance arrangements are in place. [page:1][page:2] |
| Regulatory Affairs Lead | Needs to align class, evidence, sponsor structure and market authorisation work with TGA requirements. |
| Transaction or Compliance Adviser | Needs to verify ARTG status and assess whether the Australian supply model is supportable. [web:98][page:2] |
Typical Scenarios
Practical scenarios help explain where Australian registration analysis becomes commercially important.
| Therapeutic-Good Qualification | The business must determine whether the product is a therapeutic good and whether it is a medical device in the Australian framework. [web:92][page:1] |
| Class Strategy | The company needs to identify the relevant class because the TGA classifies medical devices by the level of risk they pose. [web:95] |
| ARTG Inclusion Planning | The sponsor needs to determine whether the product must be included in the ARTG before lawful supply. [web:92][page:2] |
| Sponsor Setup | The business needs to establish the Australian sponsor relationship required for market access. TGA guidance on the inclusion process explains that before applying to include a medical device in the ARTG, a relationship with the manufacturer must be established so the sponsor can obtain documentation and ongoing information. [web:89] |
| Register Verification | The business needs to verify whether a therapeutic good is already in the public ARTG database. The TGA states that the ARTG is the public database of therapeutic goods that can be legally supplied in Australia. [web:98][page:2] |
| Post-Market Maintenance | The sponsor must manage ongoing supply, distribution and compliance responsibilities after the device enters the market. [page:1] |
Jurisdiction Characteristics
Australia is a TGA-centered medical-device market with a public register-based supply framework and a sponsor-led commercial structure. The TGA describes the medical-device journey as spanning market authorisation, supply and distribution, and monitoring and compliance. [page:1]
A distinctive practical feature is the centrality of the ARTG. The TGA states that the ARTG is the public database of therapeutic goods that can be legally supplied in Australia, which makes register status a key market-access indicator for relevant devices. [web:98][page:2]
| Operational Culture | TGA-centered, class-based and sponsor-led. |
| Legal Framework Orientation | Therapeutic goods framework with medical-device classification and ARTG inclusion as core legal-supply architecture. [page:1][page:2] |
| Commercial Context | Mature, rules-based healthcare market where lawful supply depends on the correct TGA and ARTG position. |
| Language Expectation | English-language regulatory and commercial operation is standard. |
Key Authorities
Australian medical device registration is centered on the Therapeutic Goods Administration. The TGA provides the national framework for how medical devices are regulated in Australia. [web:84][page:1]
| Official Name | Therapeutic Goods Administration |
| Official English Name | Therapeutic Goods Administration (TGA) |
| Primary Role | Australian authority responsible for the regulation of medical devices and other therapeutic goods. [web:84][page:1] |
| Responsibilities | Regulates manufacturing, application and market authorisation, supply and distribution, labelling and advertising, and monitoring and compliance for medical devices. [page:1] |
| Typical Interaction | Direct where a sponsor or manufacturer must determine product status, ARTG inclusion requirements, ongoing supply obligations or post-market compliance issues. |
| Official Website | TGA Medical Devices |
| Cross-Border Relevance | High, because foreign manufacturers rely on Australian sponsor arrangements and ARTG inclusion strategy to access the market. [web:89][page:2] |
| Official Name | Australian Register of Therapeutic Goods |
| Official English Name | Australian Register of Therapeutic Goods (ARTG) |
| Primary Role | Public database of therapeutic goods that can be legally supplied in Australia. [web:98][page:2] |
| Responsibilities | Holds public information about therapeutic goods, including sponsor and manufacturer details, and supports verification searches. [page:2] |
| Typical Interaction | Used to verify whether a product has the register status necessary for lawful supply in Australia. [web:85][page:2] |
| Official Website | About the ARTG |
| Cross-Border Relevance | High, because international manufacturers and local sponsors use the ARTG to validate market-access status. [web:98][page:2] |
Applicable Legislation
The Australian framework combines therapeutic-goods regulation, medical-device classification rules and ARTG-based supply architecture. TGA guidance on the ARTG explains that the register is the public database of therapeutic goods that can be legally supplied in Australia. [web:98][page:2]
| Official Title | Therapeutic Goods Framework for Medical Devices |
| Year | Current Australian framework |
| Purpose | Provides the legal and administrative structure for regulating medical devices and determining whether ARTG inclusion is required before supply. [page:1][web:92] |
| Typical Application | Used to determine whether the product is a therapeutic good, whether it is a medical device and whether it must be included in the ARTG. |
| Related Legislation | Therapeutic Goods Act structure, medical-device classification instruments, ARTG rules and applicable declarations or exclusions identified by the TGA. [web:92] |
| Official Source | TGA Medical Devices |
| Current Status | Active framework. [page:1][page:2] |
| Official Title | Australian Register of Therapeutic Goods Framework |
| Year | Current register framework |
| Purpose | Provides the public register mechanism through which therapeutic goods that can be legally supplied in Australia are identified. [web:98][page:2] |
| Typical Application | Used to verify whether a therapeutic good has the register status needed for lawful Australian supply. [web:85][page:2] |
| Related Legislation | TGA medical-device qualification and inclusion guidance. [page:1][web:92] |
| Official Source | About the ARTG |
| Current Status | Active register system. [page:2] |
Process Flow
Australian medical device registration normally works as a staged process from product qualification to lawful supply. The TGA’s published framework for medical devices starts with understanding what kind of medical device the product is and continues through application and market authorisation, supply and distribution, and monitoring and compliance. [page:1]
| 1. Product Qualification | Determine whether the product is a therapeutic good and a medical device in the Australian framework. [web:92][page:1] |
| 2. Class Determination | Identify the relevant class, since TGA classification is linked to risk. [web:95] |
| 3. Exemption or Inclusion Review | Confirm whether the product is exempt from ARTG inclusion or whether inclusion is required before supply. TGA guidance lists certain categories exempt from inclusion, such as some clinical-trial, special-access, personal-importation and custom-made contexts. [web:92] |
| 4. Sponsor Structure | Establish the sponsor-manufacturer relationship required to support the inclusion process and ongoing information access. [web:89] |
| 5. Documentation Readiness | Prepare the regulatory, technical, clinical and safety documentation that the TGA may request. [web:89] |
| 6. ARTG Application or Inclusion Step | Apply for inclusion where the device must be included in the ARTG before supply. [page:1][page:2] |
| 7. Register Verification | Confirm the ARTG position and search details in the public register. [web:85][page:2] |
| 8. Commercial Supply | Supply the device in Australia only after the lawful market-access position is in place. |
| 9. Ongoing Compliance | Maintain obligations relating to supply, distribution, labelling, advertising and post-market monitoring. [page:1] |
| Typical Outputs | Qualification memo, class rationale, sponsor file, ARTG inclusion record and ongoing compliance controls. |
Decision Tree
The decision tree helps simplify the main Australian threshold questions.
- Confirm whether the product is a therapeutic good and whether it is a medical device in the Australian framework. [web:92][page:1]
- Determine the device class because the TGA links classification to risk. [web:95]
- Check whether the product is excluded from being a medical device or exempt from ARTG inclusion in the specific supply context. [web:92]
- If ARTG inclusion is required, establish the sponsor structure and the relationship with the manufacturer needed for inclusion. [web:89]
- Prepare the technical, clinical, regulatory and safety information that the TGA may request. [web:89]
- Apply for inclusion and confirm the resulting ARTG position through the public register. [web:85][page:2]
- Supply only after the product has the correct legal status for Australian supply. [web:98][page:2]
- Maintain post-market and supply-chain obligations after launch. [page:1]
Timeline
The Australian timeline starts before launch and continues after supply begins. The practical path depends on whether the product requires ARTG inclusion and on the class-based regulatory route chosen.
| Concept Stage | The business defines the product, intended use and intended Australian supply model. |
| Qualification Stage | The product is assessed as a therapeutic good and medical device where applicable. [web:92][page:1] |
| Classification Stage | The device class is mapped because it affects assessment and market-authorisation logic. [web:95] |
| Inclusion Planning Stage | The business determines whether ARTG inclusion is needed or whether an exemption applies. [web:92][page:2] |
| Sponsor Stage | The sponsor relationship and access to manufacturer documentation are put in place. [web:89] |
| Application Stage | The relevant application or inclusion work is filed with the TGA where required. [page:1][page:2] |
| Supply Stage | The device is supplied only once the lawful market-access position is secured. |
| Maintenance Stage | The sponsor and business maintain compliance through supply, advertising and post-market monitoring. [page:1] |
Required Documents
The exact document set depends on class and product type, but Australian medical device registration depends on a coherent set of materials that supports qualification, inclusion and supply.
| Document | Product Qualification Record |
| Purpose | Shows why the product is a therapeutic good and a medical device in the Australian framework. [web:92][page:1] |
| Typical Situation | Prepared at the beginning of Australian registration strategy. |
| Document | Classification and Inclusion Assessment |
| Purpose | Explains the relevant class and whether ARTG inclusion is required before supply. [web:92][web:95] |
| Typical Situation | Used before the sponsor proceeds with inclusion planning. |
| Document | Sponsor-Manufacturer Relationship File |
| Purpose | Supports the sponsor’s ability to obtain regulatory, technical, clinical and safety information from the manufacturer. [web:89] |
| Typical Situation | Used before applying to include a medical device in the ARTG. [web:89] |
| Document | ARTG Inclusion Record |
| Purpose | Shows the public register position required for lawful supply in Australia. [web:98][page:2] |
| Typical Situation | Used for market launch verification and ongoing due diligence. |
| Document | Post-Market Compliance File |
| Purpose | Supports obligations related to supply, distribution, labelling, advertising and monitoring. [page:1] |
| Typical Situation | Maintained after supply begins in Australia. |
Cross-Border Relevance
Cross-border relevance is high because many non-Australian manufacturers enter the market through an Australian sponsor structure. TGA guidance on the inclusion process states that before applying to include a device in the ARTG, a relationship with the manufacturer must be established so the sponsor can obtain documentation and be kept informed of problems, safety alerts or recalls. [web:89]
The cross-border issue in Australia is therefore not simply whether the device exists elsewhere. It is whether the product has the correct Australian qualification, inclusion logic and sponsor-led market-access structure for lawful supply. [web:92][page:2]
| Recognition | Australian market access depends on TGA and ARTG status rather than on automatic recognition of another market’s device authorization. |
| Foreign Companies | Foreign manufacturers generally need an Australian sponsor structure to manage ARTG inclusion and ongoing supply obligations. [web:89] |
| Language Considerations | English is the core operating language for Australian regulatory materials and communications. |
| International Rules | Cross-border businesses should not assume that overseas approval alone creates the right to supply in Australia. [web:92][page:2] |
| Practical Considerations | Australian entry strategy should treat therapeutic-good qualification, class analysis, ARTG inclusion and sponsor structure as one integrated route-to-market architecture. |
| Typical Risk | Supplying a device through an incomplete sponsor arrangement or without verifying whether ARTG inclusion is legally required. [web:89][web:92] |
TGAARTGSponsorTherapeutic GoodMedical DeviceClass
Operating Constraints & Risks
Operating constraints identify the main failure points in Australian medical device registration. Many arise when businesses treat the ARTG as a simple listing outcome rather than the result of a correct qualification and sponsor-led market-access strategy.
| Qualification Risk | The product is misread as a medical device or non-device, which distorts the Australian route from the start. [web:92][page:1] |
| Class Risk | The wrong class is assumed, which changes the regulatory pathway. [web:95] |
| Inclusion Risk | The business assumes the device can be supplied without first determining whether ARTG inclusion is legally required. [web:92][page:2] |
| Sponsor Risk | The sponsor relationship is not structured well enough to support documentation access, recalls or safety-alert communication. [web:89] |
| Register Risk | The product’s ARTG position is not verified even though the register is the public database for goods that can be legally supplied in Australia. [web:98][page:2] |
| Post-Market Risk | The business neglects supply, distribution, advertising or monitoring responsibilities after launch. [page:1] |
| Cross-Border Risk | An overseas manufacturer assumes prior approval elsewhere automatically supports lawful Australian supply. |
Costs & Fees
Australian medical device registration costs arise from class analysis, inclusion work, sponsor operations and ongoing compliance rather than from one single step.
| Assessment Costs | Qualification analysis, class assessment and documentation preparation can be substantial depending on the device. |
| Application Costs | ARTG inclusion work, supporting evidence preparation and regulatory management create direct and indirect cost. [page:1][page:2] |
| Sponsor Costs | Australian sponsor arrangements commonly create ongoing commercial and compliance cost because the sponsor holds a continuing market-access role. [web:89] |
| Verification Costs | ARTG searching is public, but due-diligence and lifecycle maintenance around register status still create cost. [web:85][page:2] |
| Maintenance Costs | Continuing compliance through supply, labelling, advertising and monitoring adds recurring expense. [page:1] |
| Enforcement Costs | Launch delays, border issues, corrective actions or post-market compliance failures can materially increase overall costs. |
FAQ
The FAQ section addresses recurring threshold questions in Australian device market-entry work.
| What Is the ARTG? | The TGA states that the ARTG is the public database of therapeutic goods that can be legally supplied in Australia. [web:98][page:2] |
| Does Every Product Need to Be in the ARTG? | No. TGA guidance explains that some products may be exempt from inclusion in the ARTG in specific contexts, such as some clinical-trial, special-access, personal-importation and custom-made situations. [web:92] |
| How Does Australia Define a Medical Device? | The TGA states that a medical device can be any product or software, including AI, that works to achieve a therapeutic purpose in or on human beings. [web:84][page:1] |
| Why Is the Sponsor Important? | TGA guidance on the inclusion process explains that the sponsor must have a relationship with the manufacturer that allows access to documentation and ongoing problem or recall information. [web:89] |
| Can Overseas Approval Alone Authorise Supply in Australia? | No. The key issue is whether the product has the correct Australian legal basis, including ARTG status where required. [web:92][page:2] |
| Does Registration End After Launch? | No. The TGA framework includes ongoing supply, distribution, advertising and monitoring obligations after market entry. [page:1] |
Practical Guidance
Practical guidance helps a business prepare before finalising an Australian launch strategy.
| Checklist | What exactly is the product and is it a therapeutic good in Australia? Does it qualify as a medical device or IVD? What class applies? Does the product need to be included in the ARTG, or does a specific exemption apply? Has the Australian sponsor structure been established? Does the sponsor have the manufacturer relationship and access to regulatory, technical, clinical and safety information required for inclusion and ongoing supply? Has the ARTG position been verified? Have ongoing obligations relating to supply, labelling, advertising and monitoring been planned? |
A disciplined Australian registration review should start with therapeutic-good qualification and ARTG logic. In many failed launches, the visible register issue is only a later symptom of an earlier error about whether the product was a medical device, whether inclusion was required or whether the sponsor structure could support ongoing compliance. [web:92][web:89][page:1][page:2]
Jurisdictional Expert
The Jurisdictional Expert section records the status of the registry position associated with this jurisdictional object. It remains separate from the editorial content.
| Registry Position ID | RE-AU-MDR-001 |
| Registry Position | Jurisdictional Expert Medical Device Registration Australia |
| Registry Availability | Open |
| Verification Status | No verified participant currently assigned to this registry position. |
| Coverage | Australia medical device registration with emphasis on TGA regulation, ARTG inclusion, sponsor structure and lawful supply obligations. |
| Registry Reference | MAR-AU-MDR-001-A Jurisdictional Expert Position |
| Contact Information | Registry position not yet assigned. |
Machine Layer
This section contains machine-oriented registry fields retained for indexing, retrieval, system organisation and future rendering control. It may be visually minimised while remaining fully available in the HTML source.
| Object DNA | medical device registration australia tga artg sponsor therapeutic goods medical device ivd inclusion lawful supply class risk market access |
| AI Retrieval Summary | Neutral registry object describing how medical device registration operates in Australia, including TGA oversight, sponsor-based market access, ARTG inclusion, therapeutic-good qualification and ongoing lawful supply obligations. |
| Entity Index | Australia Medical Device Registration TGA ARTG Sponsor Therapeutic Goods Medical Device IVD Inclusion Class Risk |
| Machine Metadata | Registry rendering layer https://market-access-records.org/css/registry.css | Object ID AU.MDR.001 | Machine Reference MAR-AU-MDR-001-A | Internal Classification Business > Regulatory & Market Access > Medical Device Registration > Australia | Checksum 0xMDR54AU |
| Internal References | Registry Object | Jurisdiction Node | Editorial Record | Jurisdictional Expert Position | Machine-readable Reference Node |